Denosumab in bone marrow oedema syndrome. Response to Letter to the Editor of Injury
Standard
Denosumab in bone marrow oedema syndrome. Response to Letter to the Editor of Injury. / Rolvien, Tim; Schmidt, Tobias; Barvencik, Florian; Amling, Michael.
in: INJURY, Jahrgang 48, Nr. 10, 10.2017, S. 2368.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Denosumab in bone marrow oedema syndrome. Response to Letter to the Editor of Injury
AU - Rolvien, Tim
AU - Schmidt, Tobias
AU - Barvencik, Florian
AU - Amling, Michael
N1 - Letter
PY - 2017/10
Y1 - 2017/10
KW - Letter
U2 - 10.1016/j.injury.2017.07.029
DO - 10.1016/j.injury.2017.07.029
M3 - Other (editorial matter etc.)
C2 - 28784253
VL - 48
SP - 2368
JO - INJURY
JF - INJURY
SN - 0020-1383
IS - 10
ER -